Part I - Introduction to Drug delivery to the CNS Chapter 1: General physiology and function of brain Chapter 2: Formulator's challenges for delivering drugs to the brain Chapter 3: Possible targets in the management of various CNS disorders Chapter 4: Antioxidants and their possible benefits in neurodegeneration Chapter 5: Prodrug approaches for delivering CNS active agents Chapter 6: Traditional practices in CNS drug delivery Chapter 7: Emerging need of Novel Drug Delivery Systems in management of CNS disorders Chapter 8: Nose to brain drug delivery through advanced Drug Delivery Systems Chapter 9: PBPK modeling for CNS Delivery Part II - Novel Drug Delivery Systems to specific CNS Disorders Chapter 10: Novel Drug Delivery Systems in treating epilepsy Chapter 11: Novel Drug Delivery Systems in the management of Parkinson's Disease Chapter 12: Role of Novel Drug Delivery Systems in managing Alzheimer's Disease Chapter 13: Novel Drug Delivery Systems in the management of Huntington's Disease Chapter 14: Novel Drug Delivery Systems in the management of multiple sclerosis Chapter 15: Role of Novel Drug Delivery Systems in delivering antidepressant drugs to the brain Chapter 16: Delivering cancer chemotherapeutics to the brain through Novel Drug Delivery Systems Chapter 17: Novel Drug Delivery Systems in the management of Schizophrenia Chapter 18: Prospects of Novel Drug Delivery Systems in treating cerebral palsy Chapter 19: Targeting phytoconstituents to the brain through Novel Drug Delivery Systems Chapter 20: Novel Drug Delivery Systems in managing autism Chapter 21: Novel Drug Delivery Systems in amyotrophic lateral sclerosis Chapter 22: Novel Drug Delivery Systems in cerebral vascular disorders, transient ischemic attack and stroke interventions Chapter 23: Treating meningitis through Novel Drug Delivery Systems Chapter 24: Treatment of CNS infections in AIDS positive patients through Novel Drug Delivery Systems Chapter 25: Novel Drug Delivery Systems in the management of myasthenia gravis Chapter 26: Managing Concussions and traumatic brain injury through NDDS Chapter 27: Trends in delivery of drugs to brain for treatment of neuropathy Chapter 28: Delivery of antimigraine drugs to brain through Novel Drug Delivery Systems Chapter 29: Treatment of heavy metal induced neurotoxicity via advanced drug delivery systems Part III - Clinical Trials and Future Prospects Chapter 30: Exploring the potential of artificial intelligence in drug delivery to brain Chapter 31: Clinical trials in drug discovery for treatment of CNS disorders Chapter 32: Future prospects and Challenges to CNS drug delivery